Stanford University Medical Center_Site number 143 — Palo Alto, California

Stanford University Medical Center_Site number 143 is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford University Medical Center_Site number 143 has participated in 1 clinical trials.

Therapeutic areas: System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Sponsors: Kadmon, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University Medical Center_Site number 143?

Stanford University Medical Center_Site number 143 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University Medical Center_Site number 143 conducted?

Stanford University Medical Center_Site number 143 has 1 clinical trials on record. Their work covers System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Is Stanford University Medical Center_Site number 143 accredited by Crixeo Health?

Stanford University Medical Center_Site number 143 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University Medical Center_Site number 143?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.